MIRA
INFORM REPORT
|
Report Date : |
28.05.2008 |
IDENTIFICATION
DETAILS
|
Name : |
GINWON MEDICAL CO.,LTD |
|
|
|
|
Registered Office : |
Rm. 1009, Daeryung Techno Tower 6-cha, 493-6, Gasan-dong,
Geumcheon-gu, Seoul |
|
|
|
|
Country : |
Korea |
|
|
|
|
Financials (as on) : |
31.12.2004 |
|
|
|
|
Date of Incorporation : |
03.12.2001 |
|
|
|
|
Com. Reg. No.: |
130-81-77584 |
|
|
|
|
Legal Form : |
Company Limited by Shares |
|
|
|
|
Line of Business : |
Manufacture of Other Medical and Surgical Equipment and Orthopedic
Appliances |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Basic
|
Company
Name |
GINWON MEDICAL CO.,LTD |
|
Registered Address |
493-6, Gasan-dong, Geumcheon-gu, Seoul,
Korea |
|
Building |
Rm. 1009, Daeryung Techno Tower 6-cha |
|
Zip Code |
153-774 |
|
Tel |
+82-2-2108-5090~2 |
|
Fax |
+82-2-2108-5093 |
|
E-mail |
ginwoon@empal.com |
|
Website |
www.ginwon.co.kr |
|
Trading Address |
Rm. 1009, Daeryung Techno Tower 6-cha,
493-6, Gasan-dong, Geumcheon-gu, Seoul, Korea |
|
Tel |
+82-2-2108-5090~2 |
|
Fax |
+82-2-2108-5093 |
|
Other Address-Branch |
7-21, Dorim 1-dong, Yeongdeungpo-gu,
Seoul, Korea |
|
Other Address-Branch |
215-14, Singil-dong, Yeongdeungpo-gu, Seoul, Korea |
|
Type |
Export/Import |
|
Industry |
Manufacture of Other Medical and Surgical Equipment and Orthopedic
Appliances n.e.c. |
|
Main Business |
Bone Dexa Densitometer, Ender Mologie, Doppler, Electronic Tourniquet |
|
Sub Business |
Wholesale of Medical, Precision and Scientific Instruments and
Equipment |
|
Established (mm/dd/yyyy) |
03/12/2001 |
The Subject owns the
premises of registered HQ address.
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Diagnostic assessment and exam products for
general use(42181500) |
|
Sell |
Tourniquets(41104104) |
|
Sell |
Electrotherapy equipment(42141800) |
|
Sell |
Cardiac pacemakers and related
products(42203500) |
|
Sell |
Medical ultrasound bone
densitometers(42201704) |
|
Sell |
Nebulizers or accessories(42271802) |
CEO’s
|
Name |
Kim Byung-Wun |
|
Address |
310, Sinjeong-dong, Yangcheon-gu, Seoul, Korea |
|
Date of Birth |
03/01/1967 |
|
Title |
Representative Director |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital |
150,000,000 KRW |
|
Employees |
10 |
|
Formation |
Co., Ltd by shares |
|
Bank Details |
Industrial Bank of Korea-Daerim Dong Branch Hana Bank-Shingil Dong Branch |
|
Corporate Registered No. |
134911-0018885 |
|
Business Registered No. |
130-81-77584 |
|
Permit & Licenses |
Int’l Trade No.: 11445579 |
|
Shareholder Position |
N/A |
|
Company History |
03/12/2001 Incorporated as the present
name 05/27/2003 Moved to the present HQ address
from 201, Haan 3-dong, Gwangmyeong-si, Gyeonggi-do, Korea 12/13/2006 Increased capital to
150,000,000 KRW from 50,000,000 KRW |
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
Representative Director |
Mr. |
Kim Byung-Wun |
Male |
Korean |
03/12/2001 |
|
Auditor |
M/S. |
Kang Myung-Sook |
Female |
Korean |
12/27/2007 |
Financials
Unit: KRW
|
Year |
Sales |
Assets |
Net income |
|
5,041,000,000 |
|
|
|
|
2005 |
1,950,000,000 |
|
|
|
2004 |
1,492,000,000 |
972,000,000 |
35,000,000 |
|
2003 |
1,368,000,000 |
558,000,000 |
32,000,000 |
The latest & full financial is not available,
and the subject does not have any obligation to releases its financials to the
public.
Financial Description
Unit: KRW
|
Authorized
Capital |
200,000,000 |
|
Paid-Up
Capital |
150,000,000 |
|
Total Issues Shares |
30,000 |
Balance
Sheet
|
Unit : Million Korean Won |
As of 12/31/2004 |
As of 12/31/2003 |
|
Total Assets |
972 |
558 |
|
Current Assets |
573 |
159 |
|
-Quick Assets |
182 |
94 |
|
-Inventories |
391 |
65 |
|
Fixed Assets |
399 |
399 |
|
-Investment |
398 |
398 |
|
-Tangibles |
1 |
1 |
|
-Intangibles |
- |
- |
|
Total Liabilities |
810 |
431 |
|
Current Liabilities |
810 |
431 |
|
Fixed Liabilities |
- |
- |
|
Capital Stock |
50 |
50 |
|
Capital Surplus |
- |
- |
|
Profit Surplus |
112 |
77 |
|
Capital Adjustment |
- |
- |
|
Total Equity |
162 |
127 |
|
Liab. & Shareholder’s Equity |
972 |
558 |
Income
Statement
|
Unit : Million Korean Won |
As of 12/31/2004 |
As of 12/31/2003 |
|
Sales |
1,492 |
1,368 |
|
Cost of Sold Goods |
1,068 |
1,109 |
|
Gross Profit |
424 |
259 |
|
Selling & Admin. Expenses |
354 |
191 |
|
Operating Income |
70 |
68 |
|
Non-Operating Income |
11 |
2 |
|
Non-Operating expenses |
45 |
31 |
|
Ordinary Income |
36 |
39 |
|
Special Income |
- |
- |
|
Income Before Taxes |
36 |
39 |
|
Income Taxes Expenses |
1 |
7 |
|
Net Income |
35 |
32 |
Products, Technologies, Services
Description
|
Main
Products & Services |
TOURNIQUET OSTEODENSITOMETER TCD SYSTEM FIBER OPTICAL HEAD-LIGHT X-RAY FILM SCREEN FAT-THERAPY DEVICE |
Trade
Partners
|
Suppliers |
MEDI LINK-FRANCE ELCAT-GERMANY GULF MEDICAL FIBEROPTICS-USA CAWO-GERMANY MEDICAL SYSTEM-FRANCE SCANDMED-SWEDEN CARDIOSCIENCE-USA |
Sales by
Region (Activity &
Markets)
The Subject imports the medical equipments & instruments from USA, Japan,
France, Sweden and Germany.
Court
Action
Not Available.
News
Clipping
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)